Joseph P Balint

This inventor holds 24 USPTO granted patents and 5 published patent applications, plus 2 CIPO patents and 2 EPO patents, primarily in Vaccine Development. Top assignees: Etubics Corporation, Imre Corporation, Cypress Bioscience, Inc.. Active years: 1987-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Joseph P Balint. Retrieved from https://idiyas.com/inventor/joseph-p-balint

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 24 (Patent Applications = 5)

% Patents Active = 100.0

CIPO Patents = 2 (Patent Applications = 5)

EPO Patents = 2 (Patent Applications = 3)

Average Co-Inventor Count = 2.4

ph-index = 8

Forward Citations = 207(Granted Patents)

Location History:

Clifton, NJ (US) (1987)
Seattle, WA (US) (1987 - 2023)

Company Filing History:

Cypress Bioscience, Inc.

5. 1 out of 834,601

Other

patents

Years Active: 1987-2025

Loading Chart...

Areas of Expertise:

Adenovirus Vectors

Breast Cancer Vaccines

HPV Vaccines

Immunotherapy

IL-15 Superagonists

Tumor Vaccination

Alphavirus Vaccination

Flavivirus Vaccination

Affinity Chromatography

Cancer Treatment

Rheumatoid Arthritis

HIV Treatment

24 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12370250 - Methods and compositions for producing an adenovirus vector for use with multiple vaccinations (2025-07-29),

2. 11826417 - Methods and compositions for producing an adenovirus vector for use with multiple vaccinations (2023-11-28),

3. 11529408 - Methods and compositions for producing an adenovirus vector for use with multiple vaccinations (2022-12-20),

4. 11504423 - Methods and compositions for producing an adenovirus vector for use with multiple vaccinations (2022-11-22),

5. 11389521 - Methods and compositions for producing an adenovirus vector for use with multiple vaccinations (2022-07-19),

6. 11376316 - Breast cancer vaccines and methods of use thereof (2022-07-05),

7. 11369673 - HPV vaccines and methods of use thereof (2022-06-28),

8. 11344613 - Sequential administration of a replication defective adenovirus vector in vaccination protocols (2022-05-31),

9. 11304998 - Combination immunotherapies comprising IL-15 superagonists (2022-04-19),

10. 11116827 - Compositions and methods for tumor vaccination and immunotherapy involving HER antigens (2021-09-14),

11. 11104916 - Compositions and methods for alphavirus vaccination (2021-08-31),

12. 11020467 - Combination immunotherapies comprising IL-15 superagonists (2021-06-01),

13. 10835596 - Compositions and methods for flavivirus vaccination (2020-11-17),

14. 8298549 - Sequential administration of a replication defective adenovirus vector in vaccination protocols (2012-10-30),

15. 5782792 - Method for treatment of rheumatoid arthritis (1998-07-21),

Title: Innovations by Joseph P. Balint: A Journey in Biomedical Patents

Introduction

Joseph P. Balint, based in Seattle, WA, is a prolific inventor with 22 patents to his name. His work primarily focuses on advancing the field of biotechnology, specifically in the realm of adenovirus vectors for vaccinations. His dedication and innovative spirit have propelled him to make significant contributions to medical science.

Latest Patents

Among Balint’s most recent patents is a groundbreaking method and composition for producing an adenovirus vector intended for use in multiple vaccinations. This invention includes methods for generating immune responses utilizing adenovirus vectors, which enable several vaccinations with the same vector. Additionally, it addresses the challenge of vaccinating individuals who have preexisting immunity to adenovirus, thereby expanding the potential for effective vaccination strategies.

Career Highlights

Throughout his career, Joseph P. Balint has made impactful strides in biotechnology. He has worked with notable companies such as Etubics Corporation and Imre Corporation, where his innovations have influenced the development of cutting-edge medical technologies. His research has played a crucial role in enhancing the efficacy of vaccines and other therapeutic solutions.

Collaborations

Balint’s innovative journey has not been solitary. He has collaborated with esteemed colleagues, including Frank R. Jones and Richard B. Gayle. Together, they have combined their expertise to foster advancements in their field and contribute to the growth of biomedical research.

Conclusion

Joseph P. Balint stands out as an influential figure in the realm of biomedical inventions. His commitment to innovation, as evidenced by his numerous patents and collaborations, continues to pave the way for breakthroughs in vaccine development and public health. Balint’s work exemplifies the importance of creativity and collaboration in driving the future of medical science.

Profile summary based on public USPTO records.